Treatment of Noninfectious Retinal Vasculitis Using Subcutaneous Repository Corticotropin Injection
Purpose: To show whether subcutaneous repository corticotropin injection (RCI, Acthar® Gel, a repository corticotropin injection, can be an effective potential therapeutic agent for noninfectious retinal vasculitis. Methods: Patients with active retinal vasculitis were followed with serial ult...
Main Authors: | Stephen D. Anesi, Peter Y. Chang, Arash Maleki, Andrew Stephenson, Alyssa Montieth, Artur Filipowicz, Sarah Syeda, Soheila Asgari, Marisa Walsh, Jamie Lynne Metzinger, C. Stephen Foster |
---|---|
Format: | Article |
Language: | English |
Published: |
Knowledge E
2021-05-01
|
Series: | Journal of Ophthalmic & Vision Research |
Subjects: | |
Online Access: | https://doi.org/10.18502/jovr.v16i2.9086 |
Similar Items
-
Results From a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Repository Corticotropin Injection for the Treatment of Pulmonary Sarcoidosis
by: Mehdi Mirsaeidi, et al.
Published: (2023-04-01) -
A Narrative Review of Acthar Gel for the Treatment of Myositis
by: Tanya Chandra, et al.
Published: (2023-03-01) -
A Comprehensive Update on Retinal Vasculitis: Etiologies, Manifestations and Treatments
by: Aniruddha Agarwal, et al.
Published: (2022-04-01) -
The Role of Corticotropin-Releasing Hormone at Peripheral Nociceptors: Implications for Pain Modulation
by: Haiyan Zheng, et al.
Published: (2020-12-01) -
Corticotropin-Releasing Hormone: Biology and Therapeutic Opportunities
by: Alessandra Caruso, et al.
Published: (2022-12-01)